カテゴリ： 世界, 医療/バイオ, QYResearch

貧血治療薬の世界市場2023年：サプリメント、抗生物質、免疫抑制剤、骨髄刺激剤、コルチコステロイド、遺伝子治療、鉄キレート剤

■ 英語タイトル：Global Anemia Therapeutic Drugs Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8665）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8665
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：85
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[貧血治療薬の世界市場2023年：サプリメント、抗生物質、免疫抑制剤、骨髄刺激剤、コルチコステロイド、遺伝子治療、鉄キレート剤]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は貧血治療薬のグローバル市場について調査・分析し、世界の貧血治療薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（サプリメント、抗生物質、免疫抑制剤、骨髄刺激剤、コルチコステロイド、遺伝子治療、鉄キレート剤）、用途別セグメント分析（鉄欠乏性貧血、サラセミア、再生不良性貧血、溶血性貧血、鎌状赤血球貧血、悪性貧血）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Pfizer, Inc.、Amgen, Inc.、Hoffmann-La Roche Ltd.、Merck Sharp & Dohme Corp.、Novartis AG、Janssen Pharmaceutical、Bayer AG、AMAG Pharmaceuticals、GlaxoSmithKline plc、Akebia Therapeutics、Vifor Pharma Management, Ltd.、FibroGen, Inc.などが含まれています。貧血治療薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、貧血治療薬市場規模を算出する際に考慮しました。

・貧血治療薬市場の概要
- 貧血治療薬の種類別セグメント
- 世界の貧血治療薬市場規模：タイプ別分析（サプリメント、抗生物質、免疫抑制剤、骨髄刺激剤、コルチコステロイド、遺伝子治療、鉄キレート剤）
- 貧血治療薬の用途別セグメント
- 世界の貧血治療薬市場規模：用途別分析（鉄欠乏性貧血、サラセミア、再生不良性貧血、溶血性貧血、鎌状赤血球貧血、悪性貧血）
- 世界の貧血治療薬市場規模予測（2018年-2029年）

・貧血治療薬市場の成長トレンド
- 貧血治療薬の地域別市場規模（2018年-2029年）
- 貧血治療薬市場ダイナミクス
- 貧血治療薬の業界動向
- 貧血治療薬市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：サプリメント、抗生物質、免疫抑制剤、骨髄刺激剤、コルチコステロイド、遺伝子治療、鉄キレート剤
- 世界の貧血治療薬のタイプ別市場規模（2018年-2023年）
- 世界の貧血治療薬のタイプ別市場規模（2024年-2029年）

・用途別セグメント：鉄欠乏性貧血、サラセミア、再生不良性貧血、溶血性貧血、鎌状赤血球貧血、悪性貧血
- 世界の貧血治療薬の用途別市場規模（2018年-2023年）
- 世界の貧血治療薬の用途別市場規模（2024年-2029年）

・貧血治療薬の地域別市場規模
- 北米の貧血治療薬市場規模（2018年-2029年）
- 米国の貧血治療薬市場規模（2018年-2029年）
- ヨーロッパの貧血治療薬市場規模（2018年-2029年）
- アジア太平洋の貧血治療薬市場規模（2018年-2029年）
- 中国の貧血治療薬市場規模（2018年-2029年）
- 日本の貧血治療薬市場規模（2018年-2029年）
- 韓国の貧血治療薬市場規模（2018年-2029年）
- インドの貧血治療薬市場規模（2018年-2029年）
- オーストラリアの貧血治療薬市場規模（2018年-2029年）
- 中南米の貧血治療薬市場規模（2018年-2029年）
- 中東・アフリカの貧血治療薬市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Pfizer, Inc.、Amgen, Inc.、Hoffmann-La Roche Ltd.、Merck Sharp & Dohme Corp.、Novartis AG、Janssen Pharmaceutical、Bayer AG、AMAG Pharmaceuticals、GlaxoSmithKline plc、Akebia Therapeutics、Vifor Pharma Management, Ltd.、FibroGen, Inc.

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Anemia Therapeutic Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Anemia Therapeutic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Anemia Therapeutic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Anemia Therapeutic Drugs in Iron deficiency anemia is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Anemia Therapeutic Drugs include Pfizer, Inc., Amgen, Inc., Hoffmann-La Roche Ltd., Merck Sharp & Dohme Corp., Novartis AG, Janssen Pharmaceutical, Bayer AG, AMAG Pharmaceuticals and GlaxoSmithKline plc, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anemia Therapeutic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anemia Therapeutic Drugs.
The Anemia Therapeutic Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Anemia Therapeutic Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anemia Therapeutic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Pfizer, Inc.
Amgen, Inc.
Hoffmann-La Roche Ltd.
Merck Sharp & Dohme Corp.
Novartis AG
Janssen Pharmaceutical
Bayer AG
AMAG Pharmaceuticals
GlaxoSmithKline plc
Akebia Therapeutics
Vifor Pharma Management, Ltd.
FibroGen, Inc.
Segment by Type
Supplements
Antibiotics
Immunosuppressant
Bone Marrow Stimulants
Corticosteroids
Gene Therapy
Iron Chelating Agents
Segment by Application
Iron deficiency anemia
Thalassemia
Aplastic anemia
Hemolytic anemia
Sickle cell anemia
Pernicious anemia
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anemia Therapeutic Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anemia Therapeutic Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Supplements
1.2.3 Antibiotics
1.2.4 Immunosuppressant
1.2.5 Bone Marrow Stimulants
1.2.6 Corticosteroids
1.2.7 Gene Therapy
1.2.8 Iron Chelating Agents
1.3 Market by Application
1.3.1 Global Anemia Therapeutic Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Iron deficiency anemia
1.3.3 Thalassemia
1.3.4 Aplastic anemia
1.3.5 Hemolytic anemia
1.3.6 Sickle cell anemia
1.3.7 Pernicious anemia
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anemia Therapeutic Drugs Market Perspective (2018-2029)
2.2 Anemia Therapeutic Drugs Growth Trends by Region
2.2.1 Global Anemia Therapeutic Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Anemia Therapeutic Drugs Historic Market Size by Region (2018-2023)
2.2.3 Anemia Therapeutic Drugs Forecasted Market Size by Region (2024-2029)
2.3 Anemia Therapeutic Drugs Market Dynamics
2.3.1 Anemia Therapeutic Drugs Industry Trends
2.3.2 Anemia Therapeutic Drugs Market Drivers
2.3.3 Anemia Therapeutic Drugs Market Challenges
2.3.4 Anemia Therapeutic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anemia Therapeutic Drugs Players by Revenue
3.1.1 Global Top Anemia Therapeutic Drugs Players by Revenue (2018-2023)
3.1.2 Global Anemia Therapeutic Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Anemia Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anemia Therapeutic Drugs Revenue
3.4 Global Anemia Therapeutic Drugs Market Concentration Ratio
3.4.1 Global Anemia Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anemia Therapeutic Drugs Revenue in 2022
3.5 Anemia Therapeutic Drugs Key Players Head office and Area Served
3.6 Key Players Anemia Therapeutic Drugs Product Solution and Service
3.7 Date of Enter into Anemia Therapeutic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anemia Therapeutic Drugs Breakdown Data by Type
4.1 Global Anemia Therapeutic Drugs Historic Market Size by Type (2018-2023)
4.2 Global Anemia Therapeutic Drugs Forecasted Market Size by Type (2024-2029)
5 Anemia Therapeutic Drugs Breakdown Data by Application
5.1 Global Anemia Therapeutic Drugs Historic Market Size by Application (2018-2023)
5.2 Global Anemia Therapeutic Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Anemia Therapeutic Drugs Market Size (2018-2029)
6.2 North America Anemia Therapeutic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Anemia Therapeutic Drugs Market Size by Country (2018-2023)
6.4 North America Anemia Therapeutic Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anemia Therapeutic Drugs Market Size (2018-2029)
7.2 Europe Anemia Therapeutic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Anemia Therapeutic Drugs Market Size by Country (2018-2023)
7.4 Europe Anemia Therapeutic Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anemia Therapeutic Drugs Market Size (2018-2029)
8.2 Asia-Pacific Anemia Therapeutic Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Anemia Therapeutic Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Anemia Therapeutic Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anemia Therapeutic Drugs Market Size (2018-2029)
9.2 Latin America Anemia Therapeutic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Anemia Therapeutic Drugs Market Size by Country (2018-2023)
9.4 Latin America Anemia Therapeutic Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anemia Therapeutic Drugs Market Size (2018-2029)
10.2 Middle East & Africa Anemia Therapeutic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Anemia Therapeutic Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Anemia Therapeutic Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Company Detail
11.1.2 Pfizer, Inc. Business Overview
11.1.3 Pfizer, Inc. Anemia Therapeutic Drugs Introduction
11.1.4 Pfizer, Inc. Revenue in Anemia Therapeutic Drugs Business (2018-2023)
11.1.5 Pfizer, Inc. Recent Development
11.2 Amgen, Inc.
11.2.1 Amgen, Inc. Company Detail
11.2.2 Amgen, Inc. Business Overview
11.2.3 Amgen, Inc. Anemia Therapeutic Drugs Introduction
11.2.4 Amgen, Inc. Revenue in Anemia Therapeutic Drugs Business (2018-2023)
11.2.5 Amgen, Inc. Recent Development
11.3 Hoffmann-La Roche Ltd.
11.3.1 Hoffmann-La Roche Ltd. Company Detail
11.3.2 Hoffmann-La Roche Ltd. Business Overview
11.3.3 Hoffmann-La Roche Ltd. Anemia Therapeutic Drugs Introduction
11.3.4 Hoffmann-La Roche Ltd. Revenue in Anemia Therapeutic Drugs Business (2018-2023)
11.3.5 Hoffmann-La Roche Ltd. Recent Development
11.4 Merck Sharp & Dohme Corp.
11.4.1 Merck Sharp & Dohme Corp. Company Detail
11.4.2 Merck Sharp & Dohme Corp. Business Overview
11.4.3 Merck Sharp & Dohme Corp. Anemia Therapeutic Drugs Introduction
11.4.4 Merck Sharp & Dohme Corp. Revenue in Anemia Therapeutic Drugs Business (2018-2023)
11.4.5 Merck Sharp & Dohme Corp. Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Detail
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Anemia Therapeutic Drugs Introduction
11.5.4 Novartis AG Revenue in Anemia Therapeutic Drugs Business (2018-2023)
11.5.5 Novartis AG Recent Development
11.6 Janssen Pharmaceutical
11.6.1 Janssen Pharmaceutical Company Detail
11.6.2 Janssen Pharmaceutical Business Overview
11.6.3 Janssen Pharmaceutical Anemia Therapeutic Drugs Introduction
11.6.4 Janssen Pharmaceutical Revenue in Anemia Therapeutic Drugs Business (2018-2023)
11.6.5 Janssen Pharmaceutical Recent Development
11.7 Bayer AG
11.7.1 Bayer AG Company Detail
11.7.2 Bayer AG Business Overview
11.7.3 Bayer AG Anemia Therapeutic Drugs Introduction
11.7.4 Bayer AG Revenue in Anemia Therapeutic Drugs Business (2018-2023)
11.7.5 Bayer AG Recent Development
11.8 AMAG Pharmaceuticals
11.8.1 AMAG Pharmaceuticals Company Detail
11.8.2 AMAG Pharmaceuticals Business Overview
11.8.3 AMAG Pharmaceuticals Anemia Therapeutic Drugs Introduction
11.8.4 AMAG Pharmaceuticals Revenue in Anemia Therapeutic Drugs Business (2018-2023)
11.8.5 AMAG Pharmaceuticals Recent Development
11.9 GlaxoSmithKline plc
11.9.1 GlaxoSmithKline plc Company Detail
11.9.2 GlaxoSmithKline plc Business Overview
11.9.3 GlaxoSmithKline plc Anemia Therapeutic Drugs Introduction
11.9.4 GlaxoSmithKline plc Revenue in Anemia Therapeutic Drugs Business (2018-2023)
11.9.5 GlaxoSmithKline plc Recent Development
11.10 Akebia Therapeutics
11.10.1 Akebia Therapeutics Company Detail
11.10.2 Akebia Therapeutics Business Overview
11.10.3 Akebia Therapeutics Anemia Therapeutic Drugs Introduction
11.10.4 Akebia Therapeutics Revenue in Anemia Therapeutic Drugs Business (2018-2023)
11.10.5 Akebia Therapeutics Recent Development
11.11 Vifor Pharma Management, Ltd.
11.11.1 Vifor Pharma Management, Ltd. Company Detail
11.11.2 Vifor Pharma Management, Ltd. Business Overview
11.11.3 Vifor Pharma Management, Ltd. Anemia Therapeutic Drugs Introduction
11.11.4 Vifor Pharma Management, Ltd. Revenue in Anemia Therapeutic Drugs Business (2018-2023)
11.11.5 Vifor Pharma Management, Ltd. Recent Development
11.12 FibroGen, Inc.
11.12.1 FibroGen, Inc. Company Detail
11.12.2 FibroGen, Inc. Business Overview
11.12.3 FibroGen, Inc. Anemia Therapeutic Drugs Introduction
11.12.4 FibroGen, Inc. Revenue in Anemia Therapeutic Drugs Business (2018-2023)
11.12.5 FibroGen, Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Anemia Therapeutic Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Supplements
Table 3. Key Players of Antibiotics
Table 4. Key Players of Immunosuppressant
Table 5. Key Players of Bone Marrow Stimulants
Table 6. Key Players of Corticosteroids
Table 7. Key Players of Gene Therapy
Table 8. Key Players of Iron Chelating Agents
Table 9. Global Anemia Therapeutic Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Anemia Therapeutic Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Anemia Therapeutic Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Anemia Therapeutic Drugs Market Share by Region (2018-2023)
Table 13. Global Anemia Therapeutic Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 14. Global Anemia Therapeutic Drugs Market Share by Region (2024-2029)
Table 15. Anemia Therapeutic Drugs Market Trends
Table 16. Anemia Therapeutic Drugs Market Drivers
Table 17. Anemia Therapeutic Drugs Market Challenges
Table 18. Anemia Therapeutic Drugs Market Restraints
Table 19. Global Anemia Therapeutic Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Anemia Therapeutic Drugs Market Share by Players (2018-2023)
Table 21. Global Top Anemia Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anemia Therapeutic Drugs as of 2022)
Table 22. Ranking of Global Top Anemia Therapeutic Drugs Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by Anemia Therapeutic Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Anemia Therapeutic Drugs Product Solution and Service
Table 26. Date of Enter into Anemia Therapeutic Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Anemia Therapeutic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Anemia Therapeutic Drugs Revenue Market Share by Type (2018-2023)
Table 30. Global Anemia Therapeutic Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 31. Global Anemia Therapeutic Drugs Revenue Market Share by Type (2024-2029)
Table 32. Global Anemia Therapeutic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Anemia Therapeutic Drugs Revenue Market Share by Application (2018-2023)
Table 34. Global Anemia Therapeutic Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 35. Global Anemia Therapeutic Drugs Revenue Market Share by Application (2024-2029)
Table 36. North America Anemia Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Anemia Therapeutic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Anemia Therapeutic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Anemia Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 40. Europe Anemia Therapeutic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 41. Europe Anemia Therapeutic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 42. Asia-Pacific Anemia Therapeutic Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 43. Asia-Pacific Anemia Therapeutic Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 44. Asia-Pacific Anemia Therapeutic Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 45. Latin America Anemia Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Latin America Anemia Therapeutic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 47. Latin America Anemia Therapeutic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 48. Middle East & Africa Anemia Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 49. Middle East & Africa Anemia Therapeutic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 50. Middle East & Africa Anemia Therapeutic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 51. Pfizer, Inc. Company Detail
Table 52. Pfizer, Inc. Business Overview
Table 53. Pfizer, Inc. Anemia Therapeutic Drugs Product
Table 54. Pfizer, Inc. Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 55. Pfizer, Inc. Recent Development
Table 56. Amgen, Inc. Company Detail
Table 57. Amgen, Inc. Business Overview
Table 58. Amgen, Inc. Anemia Therapeutic Drugs Product
Table 59. Amgen, Inc. Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 60. Amgen, Inc. Recent Development
Table 61. Hoffmann-La Roche Ltd. Company Detail
Table 62. Hoffmann-La Roche Ltd. Business Overview
Table 63. Hoffmann-La Roche Ltd. Anemia Therapeutic Drugs Product
Table 64. Hoffmann-La Roche Ltd. Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 65. Hoffmann-La Roche Ltd. Recent Development
Table 66. Merck Sharp & Dohme Corp. Company Detail
Table 67. Merck Sharp & Dohme Corp. Business Overview
Table 68. Merck Sharp & Dohme Corp. Anemia Therapeutic Drugs Product
Table 69. Merck Sharp & Dohme Corp. Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 70. Merck Sharp & Dohme Corp. Recent Development
Table 71. Novartis AG Company Detail
Table 72. Novartis AG Business Overview
Table 73. Novartis AG Anemia Therapeutic Drugs Product
Table 74. Novartis AG Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 75. Novartis AG Recent Development
Table 76. Janssen Pharmaceutical Company Detail
Table 77. Janssen Pharmaceutical Business Overview
Table 78. Janssen Pharmaceutical Anemia Therapeutic Drugs Product
Table 79. Janssen Pharmaceutical Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 80. Janssen Pharmaceutical Recent Development
Table 81. Bayer AG Company Detail
Table 82. Bayer AG Business Overview
Table 83. Bayer AG Anemia Therapeutic Drugs Product
Table 84. Bayer AG Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 85. Bayer AG Recent Development
Table 86. AMAG Pharmaceuticals Company Detail
Table 87. AMAG Pharmaceuticals Business Overview
Table 88. AMAG Pharmaceuticals Anemia Therapeutic Drugs Product
Table 89. AMAG Pharmaceuticals Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 90. AMAG Pharmaceuticals Recent Development
Table 91. GlaxoSmithKline plc Company Detail
Table 92. GlaxoSmithKline plc Business Overview
Table 93. GlaxoSmithKline plc Anemia Therapeutic Drugs Product
Table 94. GlaxoSmithKline plc Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 95. GlaxoSmithKline plc Recent Development
Table 96. Akebia Therapeutics Company Detail
Table 97. Akebia Therapeutics Business Overview
Table 98. Akebia Therapeutics Anemia Therapeutic Drugs Product
Table 99. Akebia Therapeutics Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 100. Akebia Therapeutics Recent Development
Table 101. Vifor Pharma Management, Ltd. Company Detail
Table 102. Vifor Pharma Management, Ltd. Business Overview
Table 103. Vifor Pharma Management, Ltd. Anemia Therapeutic Drugs Product
Table 104. Vifor Pharma Management, Ltd. Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 105. Vifor Pharma Management, Ltd. Recent Development
Table 106. FibroGen, Inc. Company Detail
Table 107. FibroGen, Inc. Business Overview
Table 108. FibroGen, Inc. Anemia Therapeutic Drugs Product
Table 109. FibroGen, Inc. Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)
Table 110. FibroGen, Inc. Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anemia Therapeutic Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Anemia Therapeutic Drugs Market Share by Type: 2022 VS 2029
Figure 3. Supplements Features
Figure 4. Antibiotics Features
Figure 5. Immunosuppressant Features
Figure 6. Bone Marrow Stimulants Features
Figure 7. Corticosteroids Features
Figure 8. Gene Therapy Features
Figure 9. Iron Chelating Agents Features
Figure 10. Global Anemia Therapeutic Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 11. Global Anemia Therapeutic Drugs Market Share by Application: 2022 VS 2029
Figure 12. Iron deficiency anemia Case Studies
Figure 13. Thalassemia Case Studies
Figure 14. Aplastic anemia Case Studies
Figure 15. Hemolytic anemia Case Studies
Figure 16. Sickle cell anemia Case Studies
Figure 17. Pernicious anemia Case Studies
Figure 18. Anemia Therapeutic Drugs Report Years Considered
Figure 19. Global Anemia Therapeutic Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 20. Global Anemia Therapeutic Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 21. Global Anemia Therapeutic Drugs Market Share by Region: 2022 VS 2029
Figure 22. Global Anemia Therapeutic Drugs Market Share by Players in 2022
Figure 23. Global Top Anemia Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anemia Therapeutic Drugs as of 2022)
Figure 24. The Top 10 and 5 Players Market Share by Anemia Therapeutic Drugs Revenue in 2022
Figure 25. North America Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. North America Anemia Therapeutic Drugs Market Share by Country (2018-2029)
Figure 27. United States Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Canada Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Europe Anemia Therapeutic Drugs Market Share by Country (2018-2029)
Figure 31. Germany Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Asia-Pacific Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Asia-Pacific Anemia Therapeutic Drugs Market Share by Region (2018-2029)
Figure 39. China Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Japan Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Latin America Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Latin America Anemia Therapeutic Drugs Market Share by Country (2018-2029)
Figure 47. Mexico Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Brazil Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Anemia Therapeutic Drugs Market Share by Country (2018-2029)
Figure 51. Turkey Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Pfizer, Inc. Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)
Figure 54. Amgen, Inc. Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)
Figure 55. Hoffmann-La Roche Ltd. Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)
Figure 56. Merck Sharp & Dohme Corp. Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)
Figure 57. Novartis AG Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)
Figure 58. Janssen Pharmaceutical Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)
Figure 59. Bayer AG Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)
Figure 60. AMAG Pharmaceuticals Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)
Figure 61. GlaxoSmithKline plc Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)
Figure 62. Akebia Therapeutics Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)
Figure 63. Vifor Pharma Management, Ltd. Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)
Figure 64. FibroGen, Inc. Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 結膜炎治療薬の世界市場2023年：抗生物質、肥満細胞安定剤、コルチコステロイド、その他
  • 血管炎治療のグローバル市場（2022年-2029年）：生物製剤、コルチコステロイド、免疫抑制剤
  • 潰瘍性大腸炎治療オプションの世界市場2023年：抗炎症薬、免疫抑制剤、その他医薬品
  • 脳転移治療薬の世界市場2023年：抗けいれん薬、コルチコステロイド、化学療法薬、その他
  • クローン病治療薬のグローバル市場展望 2023年-2029年：抗炎症剤、免疫系抑制剤、抗生物質、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8665 )"貧血治療薬の世界市場2023年：サプリメント、抗生物質、免疫抑制剤、骨髄刺激剤、コルチコステロイド、遺伝子治療、鉄キレート剤" (英文：Global Anemia Therapeutic Drugs Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。